Soy at the Crossroads
The pendulum swings back from excess supplementation to downright formulating affordable, tasty and nutritious meat products.
It is not an overstatement to conclude that at the onset of the 21st century, the US soy protein corporations have fallen victim to proliferation of processing technology, ecological disputes and hyping nutritional benefits. Yet in terms of economics and organoleptical performance, soy protein ingredients remain undisputed and offer cost-effective solutions and technological supremacy. It is obvious that US soy protein companies have come to a crossroad and will be expected to quickly address an avalanche of negative perceptions head-on. The overriding question is how to reposition the benefits of functional soy protein while also accepting the fact that foreign competition has permanently eroded profit margins, much to the chagrin of shareholders.